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adenomatous polyps increases during oral calcium supplementation
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Summary To study the effect of oral supplemental calcium on colonic epithelial proliferation, 17
adenomatous polyp patients received 1.5gCa2+ as calcium carbonate daily during 12 weeks, while on a
calcium constant diet, based on the patients' habitual diet. Seven subsequently continued calcium supplemen-
tation for 9 months without dietary restrictions. Epithelial proliferation rate in colonic biopsies, expressed as
labelling index (%), was determined with 5-bromodeoxyuridine and immunohistochemistry. Biopsies were
taken from the midsigmoid at time of polyp excision and at the end of the intervention period. Median
labelling index increased from 6.1% before to 8.7% after 12 weeks calcium (n = 17, P<0.02). This was due to
increased labelling in the basal third of the crypts (11.9 vs 16%), whereas labelling in mid and luminal
compartments was not affected. Labelling index remained increased after I year calcium supplementation at
8.8%. Crypt length was not affected by calcium. These results are in contrast to those of others, who have
shown a decrease of rectal epithelial proliferation during similar doses of calcium. Therefore, the effect of
nutritional intervention on colonic epithelial proliferation should be studied in biopsies taken not only from
the rectum, but also from more proximal parts of the colon. Caution with respect to large scale intervention
studies with calcium in high risk groups is mandatory.
Nutritional factors are of major importance in the etiology of
colon cancer (Weisburger & Wynder, 1987). Therefore atten-
tion has been focused recently on possible ways to reduce
cancer risk by dietary modifications. In this respect calcium.
has been suggested to be a promising nutritional component
(Newmark et al., 1984). Several investigators have found that
supplemental dietary calcium reduces the epithelial prolifera-
tion rate in rectal mucosa in subjects at an increased risk for
colon cancer (Lipkin & Newmark, 1985; Rozen et al., 1989).
Hyperproliferation of colonic epithelium has repeatedly been
shown to be associated with an increased cancer risk (Terp-
stra et al., 1987; Scalmati et al., 1990; Risio et al., 1991) and
reduction of the proliferation rate may thus indicate a
beneficial effect with respect to tumorigenesis. However, in
the studies on the effect of calcium so far reported, prolifera-
tion was measured in rectal epithelium, whereas epidemio-
logical surveys have shown that nutritional risk factors for
rectal and colonic cancer are not the same (Ziegler et al.,
1986). The favourable effect of calcium on rectal epithelium
may therefore not be extrapolated automatically to the col-
onic epithelium. Another point is that patients enrolled in
previous studies were not given dietary guidelines to keep
dietary calcium intake constant during calcium supplementa-
tion and thus it could not be excluded that the effects of
calcium supplementation were modified by unforeseen changes
in the intake of dietary calcium. Therefore, we performed an
intervention study with oral calcium supplementation in
patients with an increased cancer risk and used the epithelial
proliferation rate in the mucosa of the sigmoid as parameter.
During the study patients were kept on a calcium-constant
diet.
Materials and methods
Patients
Consecutive patients with histologically proven adenomatous
colorectal polyps were eligible. Polyps were found and
excised during flexible endoscopy. Previous to polypectomy
biopsies were taken for proliferation measurements as de-
scribed below. Patients with other colonic abnormalities,
especially colitis, members of families affected with familial
adenomatous polyposis or hereditary nonpolyposis colon
cancer (Lynch syndrome) and patients with previous colonic
surgery were excluded. After histological verification of the
adenomatous nature of the polyp(s), patients were informed
about the study and were asked to participate. Seventeen
patients, 11 men and six women, agreed to take part in the
study. Their mean age was 56 (range 39-69) years. Informed
consent was obtained and the study was approved by the
medical ethical committee of the University Hospital of
Groningen.
Epithelial cellproliferation
Colonic epithelial cell proliferation was examined in the mid-
sigmoid. To this end three biopsies were taken at 30 cm from
the anal verge. Proliferation rate was determined by incuba-
tion of the biopsies with the thymidine analogue 5-bro-
modeoxyuridine (BrdU) and then visualising BrdU-labelled
cells using immunohistochemistry as previously described
(Welberg et al., 1990). The proliferation rate was expressed
as labelling index (LI) which is the number of labelled nuclei
divided by the total number of nuclei times hundred (%).
Only whole length cut crypts, containing at least 70 cells were
used. Because length cut crypts are limited, we previously
determined the minimal number of crypts necessary to obtain
a reliable LI (Welberg et al., 1990). Using the method of the
running average we found this number to be 12. By dividing
crypts in three compartments of equal length, LI of luminal,
mid and basal compartments were determined. Slides were
counted under blinded condition.
Studyprotocol
After a dietary history taken by a dietician, patients were
instructed to use a calcium constant diet, based on their own
habitual diet, during the 13-week study period. Before the
start of calcium supplementation patients used their diet
during 1 week and collected faeces and urine during the last
24 h of this week. They then started to take 1.5 g Ca2" as
calcium carbonate daily and continued this during 12 weeks.
The calcium tablets were taken thrice a day with the meals.
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During the last week of the study period 24 h faeces and
urine were collected again and biopsies were taken during
flexible endoscopy. Calcium contents in faeces and urine were
measured before and at the end of the intervention period as
previously described (Van der Meer et al., 1990b).
The first seven patients were asked to continue calcium
carbonate after the 12 weeks intervention period, without
adhering to the strictly calcium constant diet. These were
biopsied again a year after start of calcium supplementation.
Based on the initial results no further patients were requested
to continue calcium after the first 12 weeks.
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Results of LI of total crypts and crypt compartments are
presented as medians and ranges. Comparison of LI before
and during calcium was made using the Wilcoxon test for
paired results.
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Results
The calcium tablets were well tolerated by the patients. No
mention was made about side effects, when asked for them.
The mean (± s.e.m.) number of crypts counted for the
determination of the LI's was 17 ± 1, the mean number of
nuclei counted was 1520 + 63, and the mean number of
BrdU-labelled nuclei was 134 ± 12 (Table I).
The median labelling index at initial biopsy in this group
of polyp-patients was 6.1% (Figure 1). This is slightly but
significantly higher than previously reported values from 10
subjects with a normal colon, who had a median LI of 5.4
(4.0- 10.3)%, when determined by the same technique
(Welberg et al., 1990). During 12-weeks calcium supplemen-
tation the LI in the polyp patients increased to a median of
8.7% (P<0.02) (Figure 1). This effect was mainly due to an
increase of LI in the basal part of the crypts. LI's in the mid
and luminal crypt segments were not significantly affected by
calcium (Table I).
The increase of epithelial proliferation rate during calcium
sustained at longer follow-up. Median LI in the seven
patients, biopsied after 1 year calcium supplementation, was
8.8 (5.9-11.2)%. When comparisons were made for this
subgroup between LI at the start of the study and after 3 and
12 months of calcium, also an increase (P<0.05) was found,
from 5.9 (5.4-8.3)% before calcium to 8.7 (3.9-14.2)% after
3 months and 8.8% after 12 months of calcium (Table I).
Calcium did not affect the length of colonic crypts. Mean
(± s.d.) crypt length before calcium was 46 ± 6 cells and
after 3 months calcium 47 ± 7 cells.
Compliance with diet and calcium tablets proved to be
excellent. Total 24 h calcium excretion (mean ± s.d.) in faeces
Table I Mean (s.e.m.) numbers of crypts, nuclei and BrdU-labelled
nuclei, counted in biopsies and median (range) labelling index in the
whole crypt and in the luminal, mid and basal crypt compartments,
before, after 12 weeks and after 1 year of calcium supplementation
Before After 12 wks After I yr
n = 17 n = 17 n = 7
Crypts 17 16 18
(1) (1) (1) All nuclei 1479 1554 1534
(89) (122) (92)
BrdU-labelled 112 156 134
(15) (23) (28) LI total 6.1% 8.7%b 8.8%a
(4.5-17.3) (3.9-19.5) (5.9-11.2)
LI luminal 0.4% 0.9% 0.4%
(0.0-4.4) (0.0-2.6) (0.0-2.1)
LI mid 7.2% 9.0% 8.5%
(3.6-15.0) (3.4-29.9) (3.8-12.4)
LI basal 11.9% 16.4%c 17.1%b
(5.6-37.5) (7.9-32.3) (10.8-28.9)
ap<o.o5 bp<0.02, CP<0.0l vs before calcium.
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Figure 1 Individual and median (connected by underbroken
line) labelling indexes (%) in 17 patients with adenomatous
polyps before (LI,) and after (LI2) 12 weeks supplementation with
1.5 g Ca2+.
and urine at the end of the first week of the study period,
without calcium supplementation, was 38.5 ± 22.8 mmol
(n = 15). During the last week of the supplementation period
the 24 h excretion was 71.1 ± 32.4 mmol (n = 15). Since
35.5 mmol Ca2+ was given each day, the recovery was 92%.
Discussion
This study shows that oral calcium supplementation causes
an increase ofepithelial cell proliferation in biopsies from the
sigmoid of patients with adenomatous polyps. This result is
in contrast with those of several other groups ofinvestigators
(Lipkin et al., 1985; Rozen et al., 1989; Barsoum et al., 1992;
Wargovich et al., 1992) who have shown a decrease of rectal
epithelial proliferative activity during administration of cal-
cium in similar doses. However, only the latter two studies
were controlled, and in two other controlled studies
(Gregoire et al., 1989; Stern et al., 1990) no effect of calcium
supplementation was found. Our study also lacked a control
group, but the strength of the results was increased by the
finding that proliferation rate remained at the same elevated
level during continued calcium supplementation. As opposed
to other studies our patients were instructed to keep a
calcium-constant diet which was well complied with. Thus
the effects on colonic cell proliferation can be ascribed to the
supplemental calcium and were not due to some unforeseen
modification in the intake of dietary calcium.
Lipkin et al. (1989) recognised in a group of subjects at
risk for familial colon cancer, so called responders and non-
responders to calcium. The former proved to have a higher
mean initial labelling index compared to the latter. This
suggests that the degree of hyperproliferation may affect the
effects of calcium. We could not confirm this in our patients.
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Nearly all showed an increase of LI during calcium supple-
mentation, also those, except two, with a LI in the higher
range.
The supposition about the beneficial effects of calcium on
the colon has been supported by the results of several
epidemiologic studies (Garland et al., 1985; Kune et al., 1987;
Slattery et al., 1988). However, this effect could not be found
in all studies (Heilbrun et al., 1986; Negri et al., 1990).
Differences in dietary sources ofcalcium and other confound-
ing factors in the nutritional patterns of the populations
studied might account for the observed differences. The same
may be true for the discrepancy between our data and those
of others in regard to the epithelial proliferation rate. It is
noteworthy in this respect that our patients probably had a
much higher dietary calcium intake than the subjects studied
by Lipkin et al. (1985) and by Wargovich et al. (1992).
Whereas the latter ones had a daily intake of around 700 mg,
our patients had a 24 h calcium excretion of about 1,600 mg.
Although this value probably slightly overestimates 24 h
intake, due to the fact that not all patients had daily defeca-
tion, a clear difference seems to exist. It is therefore man-
datory that in future intervention studies attention will be
paid to the composition of the diet.
An important and perhaps essential difference between this
study and others is the site in the intestine for determination
of the proliferation rate. In the studies published so far
biopsies were taken from the rectum (Lipkin & Newmark,
1985; Rozen et al., 1989; Gregoire et al., 1989; Stern et al.,
1990; Barsoum et al., 1992; Wargovich et al., 1992), whereas
we took them from the sigmoid. This may have had impor-
tant implications for the effect of calcium. From
epidemiological surveys it has become apparent that there are
differences in the association of dietary factors with colon
cancer on the one hand and with rectal cancer on the other
(Ziegler et al., 1986). Such a difference may also exist for
calcium. However, the previously mentioned epidemiological
studies suggest that the protective effect of calcium is not
limited to the rectum but implies the whole large bowel
(Garland et al., 1985; Kune et al., 1987; Slattery et al., 1988).
It should thus be considered whether the discrepancy with
other studies is due to specific untoward effects of the mode
of calcium intervention on the sigmoid epithelium. We have
previously shown favourable effects of calcium carbonate on
duodenal bile acid composition (Van der Meer et al., 1990b)
and on some characteristics of the faecal water, including its
cytotoxicity in vitro (Van der Meer et al., 1990a). On the
other hand, calcium carbonate is generally stated to be a
constipating agent. This quality could lead to a prolongation
of colonic transit time and thereby of the exposure time of
the colonic epithelium to intestinal contents. This may result
in an increase in epithelial damage by toxic components
despite their lower concentrations in the faecal material.
Since under normal circumstances the rectum is only filled
shortly before defecation (McNeil et al., 1981), the
favourable change in faecal composition by calcium can have
its beneficial effects on rectal epithelium, whereas the
epithelium of the distal colon can be affected untowardly by
the prolonged residence of faeces there.
Faecal pH increases during calcium carbonate admini-
stration by about 0.3 pH-units (Van der Meer et al., 1990b).
A high faecal pH has been hypothesised to be associated with
an increased risk for colonic cancer (Thornton, 1981) and
there is epidemiologic evidence to support this (Walker et al.,
1986). It is questionable however, whether such small
modification of faecal pH in the range around 6.5, as caused
by calcium carbonate, might have implications for the col-
onic epithelium.
It is concluded, that there is no single explanation for the
observed differences between the responses of the epithelium
to calcium in the sigmoid and the rectum. Nevertheless our
observations may have several implications for current and
future investigations on the possible role of calcium in the
prevention ofcolon cancer. As previously mentioned, in most
studies performed so far biopsies have been taken from the
rectal mucosa. From our results it seems mandatory to
modify this practice and to take biopsies also from more
proximal parts of the colon, including the sigmoid. Further-
more, calcium carbonate may not be the right formula for
intervention and it should be considered to study other cal-
cium compounds or to combine calcium with other measures,
for example fibre. Recently some large-scale intervention
studies with calcium have been launched in several countries.
A prudent approach with respect to these studies seems to be
warranted in view of our results. More data about the effects
of calcium on the epithelium of the whole large bowel and
about the mechanisms through which these effects are being
mediated, should be collected.
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